Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05066178
NA

Speech Treatment for Minimally Verbal Children With ASD and CAS

Sponsor: MGH Institute of Health Professions

View on ClinicalTrials.gov

Summary

Comorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder affecting speech movement planning. This study tests whether CAS-specific treatment, appropriately modified for minimally verbal children with autism, improves their speech.

Key Details

Gender

All

Age Range

5 Years - 18 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2024-05-01

Completion Date

2030-11-30

Last Updated

2026-03-30

Healthy Volunteers

No

Interventions

BEHAVIORAL

CAS Treatment for Minimally Verbal Children with Autism

Treatment involves principles of motor learning embedded in a naturalistic developmental milieu

Locations (1)

MGH Institute of Health Professions

Boston, Massachusetts, United States